<p>摩特世（NYSE:WAT - 获取免费报告）在周二发布的研究报告中，分析师将其目标价格从 370.00 美元上调至 400.00 美元，彭博社报道。该券商目前对这家医疗仪器供应商的股票给予 “中性” 评级。摩特世的目标价格暗示该公司当前价格有 7.78% 的潜在上涨空间。</p>
<ul>
<li>安捷伦科技因 “永恒化学品” 打击而蓬勃发展</li>
</ul>
<p>WAT 还受到其他多份研究报告的关注。摩根士丹利在 2 月 22 日的研究报告中将摩特世的目标价格从 423.00 美元下调至 350.00 美元，并给予该公司 “等权重” 评级。Weiss Ratings 在 4 月 20 日的研究报告中重申了对摩特世股票的 “持有（c）” 评级。富国银行在 5 月 14 日的研究报告中将摩特世的目标价格从 355.00 美元上调至 370.00 美元，并给予该公司 “等权重” 评级。TD Cowen 在 5 月 6 日的研究报告中将摩特世的目标价格从 345.00 美元上调至 385.00 美元，并给予该股票 “持有” 评级。最后，古根海姆在 2 月 10 日的研究报告中重新发布了 “买入” 评级，并对摩特世股票设定了 440.00 美元的目标价格。三位分析师给予该股票 “强烈买入” 评级，九位给予 “买入” 评级，八位给予 “持有” 评级。根据 MarketBeat.com 的数据，摩特世目前的共识评级为 “适度买入”，平均目标价格为 395.71 美元。</p>
<p><strong>查看我们对摩特世的最新股票分析</strong></p>
<h2>摩特世股票表现</h2>
<ul>
<li>医疗股票摩特世、安捷伦、Illumina 显示增长潜力</li>
</ul>
<p>周二中午交易时，WAT 的股价下跌 5.86 美元，跌至 371.11 美元。该股票的交易量为 1,529,432 股，而其平均交易量为 1,186,656 股。该公司的市值为 364.4 亿美元，市盈率为 47.49，市盈增长比率为 2.42，贝塔值为 1.21。该公司的 50 日简单移动平均线为 325.28 美元，200 日简单移动平均线为 350.93 美元。该公司的速动比率为 1.13，流动比率为 1.79，债务与股本比率为 0.32。摩特世的 52 周低点为 275.05 美元，52 周高点为 414.15 美元。</p>
<p>摩特世（NYSE:WAT - 获取免费报告）在 5 月 5 日最后发布了其财报。这家医疗仪器供应商报告本季度每股收益为 2.70 美元，超出市场共识预期的 2.31 美元，超出幅度为 0.39 美元。该公司本季度的收入为 12.7 亿美元，而分析师预期为 12 亿美元。摩特世的股本回报率为 15.60%，净利润率为 11.91%。该公司的收入同比增长 91.4%。去年同期，该公司每股收益为 2.25 美元。摩特世已将其 2026 年第二季度的指导目标设定为 2.950-3.050 美元每股收益，并将其 2026 财年的指导目标设定为 14.400-14.600 美元每股收益。平均而言，股票分析师预计摩特世今年将发布 14.5 美元的每股收益。</p>
<h2>内部买卖</h2>
<p>在相关消息中，董事魏江在 3 月 16 日的交易中购买了 500 股该股票。该股票的平均购买成本为每股 289.46 美元，总价值为 144,730.00 美元。交易后，该董事持有公司 3,441 股股票，价值 996,031.86 美元。这代表其持股增加了 17.00%。该购买在向证券交易委员会提交的文件中披露，文件可通过 SEC 网站访问。内部人士持有公司 0.31% 的股票。</p>
<h2>机构投资者对摩特世的看法</h2>
<p>一些对冲基金最近对该公司的持仓进行了调整。先锋集团在第三季度将其在摩特世股票中的持股增加了 3.3%。先锋集团目前持有摩特世医疗仪器供应商的 7,656,891 股股票，价值 2,295,612,000 美元，在此期间又购买了 246,128 股。Fundsmith LLP 在第三季度将其在摩特世股票中的持股增加了 9.6%。Fundsmith LLP 目前持有摩特世医疗仪器供应商的 3,955,498 股股票，价值 1,185,898,000 美元，在此期间又购买了 347,091 股。Janus Henderson Group PLC 在第一季度将其在摩特世股票中的持股增加了 27.0%。Janus Henderson Group PLC 目前持有摩特世医疗仪器供应商的 1,638,772 股股票，价值 488,028,000 美元，在此期间又购买了 348,379 股。Geode Capital Management LLC 在第四季度将其在摩特世股票中的持股增加了 0.5%。Geode Capital Management LLC 目前持有摩特世医疗仪器供应商的 1,593,388 股股票，价值 602,921,000 美元，在此期间又购买了 8,590 股。最后，景顺有限公司在第三季度将其在摩特世股票中的持股增加了 32.3%。景顺有限公司目前持有摩特世医疗仪器供应商的 1,472,419 股股票，价值 441,446,000 美元，在上个季度又购买了 359,596 股。94.01% 的股票目前由机构投资者持有。</p>
<h2>摩特世公司简介</h2>
<p>（获取免费报告）</p>
<p>摩特世公司是一家全球性的分析仪器、软件和服务提供商，专注于实验室和研究应用。该公司设计、制造和销售以液相色谱、质谱、分离科学及相关样品准备和检测系统为中心的技术。其产品组合包括色谱仪、质谱仪、色谱柱和耗材、实验室信息学和工作流程软件，以及帮助客户进行复杂分析的技术支持和培训服务。</p>
<p>摩特世服务于广泛的终端市场，包括制药和生物技术公司、合同研究和测试实验室、学术和政府研究机构、临床诊断、食品和环境检测，以及工业和化学制造商。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票比沃特世更好</li>
<li>FirstCash 将典当业务转变为增长机器</li>
<li>HubSpot 刚刚击碎了空头论——更大的反弹在前吗？</li>
<li>激进的内部人士买入信号在三只风险股票中显示机会</li>
<li>光速：五只推动人工智能光学未来的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在沃特世吗？</h2>
<p>在考虑沃特世之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而沃特世并不在名单上。</p>
<p>虽然沃特世目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

沃特世

<p>美国银行将沃特世（NYSE:WAT）的目标股价从 370 美元上调至 400 美元，维持 “中性” 评级。这一调整是在其他分析师行动之后，包括摩根士丹利的下调和富国银行的上调。该股票最近公布了强劲的第一季度财报，EPS 和收入均超出预期，收入同比增长 91.4%。像先锋集团和 Fundsmith 这样的机构投资者在第三季度增加了他们的持股</p>

<p>Waters (NYSE:WAT - Get Free Report) had its target price lifted by analysts at Bank of America from $370.00 to $400.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has a &#34;neutral&#34; rating on the medical instruments supplier's stock. Bank of America's target price suggests a potential upside of 7.78% from the company's current price.</p>
<div class="lb-trans"><p>摩特世（NYSE:WAT - 获取免费报告）在周二发布的研究报告中，分析师将其目标价格从 370.00 美元上调至 400.00 美元，彭博社报道。该券商目前对这家医疗仪器供应商的股票给予 “中性” 评级。摩特世的目标价格暗示该公司当前价格有 7.78% 的潜在上涨空间。</p>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷伦科技因 “永恒化学品” 打击而蓬勃发展</li>
</ul>
</div><p>WAT has been the subject of a number of other research reports. Morgan Stanley reduced their price objective on Waters from $423.00 to $350.00 and set an &#34;equal weight&#34; rating for the company in a research report on Sunday, February 22nd. Weiss Ratings reaffirmed a &#34;hold (c)&#34; rating on shares of Waters in a research note on Monday, April 20th. Wells Fargo &amp; Company lifted their target price on Waters from $355.00 to $370.00 and gave the company an &#34;equal weight&#34; rating in a research note on Thursday, May 14th. TD Cowen boosted their price objective on Waters from $345.00 to $385.00 and gave the stock a &#34;hold&#34; rating in a research note on Wednesday, May 6th. Finally, Guggenheim reissued a &#34;buy&#34; rating and issued a $440.00 price objective on shares of Waters in a research note on Tuesday, February 10th. Three analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and eight have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Waters presently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $395.71.</p>
<div class="lb-trans"><p>WAT 还受到其他多份研究报告的关注。摩根士丹利在 2 月 22 日的研究报告中将摩特世的目标价格从 423.00 美元下调至 350.00 美元，并给予该公司 “等权重” 评级。Weiss Ratings 在 4 月 20 日的研究报告中重申了对摩特世股票的 “持有（c）” 评级。富国银行在 5 月 14 日的研究报告中将摩特世的目标价格从 355.00 美元上调至 370.00 美元，并给予该公司 “等权重” 评级。TD Cowen 在 5 月 6 日的研究报告中将摩特世的目标价格从 345.00 美元上调至 385.00 美元，并给予该股票 “持有” 评级。最后，古根海姆在 2 月 10 日的研究报告中重新发布了 “买入” 评级，并对摩特世股票设定了 440.00 美元的目标价格。三位分析师给予该股票 “强烈买入” 评级，九位给予 “买入” 评级，八位给予 “持有” 评级。根据 MarketBeat.com 的数据，摩特世目前的共识评级为 “适度买入”，平均目标价格为 395.71 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on Waters</strong></p>
<div class="lb-trans"><p><strong>查看我们对摩特世的最新股票分析</strong></p>
</div><h2>Waters Stock Performance</h2>
<div class="lb-trans"><h2>摩特世股票表现</h2>
</div><ul>
<li>Medical Stocks Waters, Agilent, Illumina Show Growth Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>医疗股票摩特世、安捷伦、Illumina 显示增长潜力</li>
</ul>
</div><p>Shares of WAT traded down $5.86 during mid-day trading on Tuesday, hitting $371.11. The stock had a trading volume of 1,529,432 shares, compared to its average volume of 1,186,656. The company has a market cap of $36.44 billion, a PE ratio of 47.49, a PEG ratio of 2.42 and a beta of 1.21. The company's fifty day simple moving average is $325.28 and its two-hundred day simple moving average is $350.93. The company has a quick ratio of 1.13, a current ratio of 1.79 and a debt-to-equity ratio of 0.32. Waters has a fifty-two week low of $275.05 and a fifty-two week high of $414.15.</p>
<div class="lb-trans"><p>周二中午交易时，WAT 的股价下跌 5.86 美元，跌至 371.11 美元。该股票的交易量为 1,529,432 股，而其平均交易量为 1,186,656 股。该公司的市值为 364.4 亿美元，市盈率为 47.49，市盈增长比率为 2.42，贝塔值为 1.21。该公司的 50 日简单移动平均线为 325.28 美元，200 日简单移动平均线为 350.93 美元。该公司的速动比率为 1.13，流动比率为 1.79，债务与股本比率为 0.32。摩特世的 52 周低点为 275.05 美元，52 周高点为 414.15 美元。</p>
</div><p>Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 EPS for the quarter, topping the consensus estimate of $2.31 by $0.39. The company had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.20 billion. Waters had a return on equity of 15.60% and a net margin of 11.91%.The business's revenue was up 91.4% on a year-over-year basis. During the same quarter last year, the firm earned $2.25 EPS. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. On average, equities analysts expect that Waters will post 14.5 earnings per share for the current year.</p>
<div class="lb-trans"><p>摩特世（NYSE:WAT - 获取免费报告）在 5 月 5 日最后发布了其财报。这家医疗仪器供应商报告本季度每股收益为 2.70 美元，超出市场共识预期的 2.31 美元，超出幅度为 0.39 美元。该公司本季度的收入为 12.7 亿美元，而分析师预期为 12 亿美元。摩特世的股本回报率为 15.60%，净利润率为 11.91%。该公司的收入同比增长 91.4%。去年同期，该公司每股收益为 2.25 美元。摩特世已将其 2026 年第二季度的指导目标设定为 2.950-3.050 美元每股收益，并将其 2026 财年的指导目标设定为 14.400-14.600 美元每股收益。平均而言，股票分析师预计摩特世今年将发布 14.5 美元的每股收益。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖</h2>
</div><p>In related news, Director Wei Jiang purchased 500 shares of the stock in a transaction that occurred on Monday, March 16th. The stock was acquired at an average cost of $289.46 per share, with a total value of $144,730.00. Following the transaction, the director owned 3,441 shares of the company's stock, valued at $996,031.86. This represents a 17.00% increase in their position. The purchase was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. Insiders own 0.31% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，董事魏江在 3 月 16 日的交易中购买了 500 股该股票。该股票的平均购买成本为每股 289.46 美元，总价值为 144,730.00 美元。交易后，该董事持有公司 3,441 股股票，价值 996,031.86 美元。这代表其持股增加了 17.00%。该购买在向证券交易委员会提交的文件中披露，文件可通过 SEC 网站访问。内部人士持有公司 0.31% 的股票。</p>
</div><h2>Institutional Investors Weigh In On Waters</h2>
<div class="lb-trans"><h2>机构投资者对摩特世的看法</h2>
</div><p>A number of hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. grew its stake in shares of Waters by 3.3% during the 3rd quarter. Vanguard Group Inc. now owns 7,656,891 shares of the medical instruments supplier's stock worth $2,295,612,000 after acquiring an additional 246,128 shares during the period. Fundsmith LLP raised its stake in shares of Waters by 9.6% during the 3rd quarter. Fundsmith LLP now owns 3,955,498 shares of the medical instruments supplier's stock valued at $1,185,898,000 after purchasing an additional 347,091 shares during the period. Janus Henderson Group PLC raised its stake in shares of Waters by 27.0% during the 1st quarter. Janus Henderson Group PLC now owns 1,638,772 shares of the medical instruments supplier's stock valued at $488,028,000 after purchasing an additional 348,379 shares during the period. Geode Capital Management LLC raised its stake in shares of Waters by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 1,593,388 shares of the medical instruments supplier's stock valued at $602,921,000 after purchasing an additional 8,590 shares during the period. Finally, Invesco Ltd. raised its holdings in shares of Waters by 32.3% in the 3rd quarter. Invesco Ltd. now owns 1,472,419 shares of the medical instruments supplier's stock valued at $441,446,000 after acquiring an additional 359,596 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>一些对冲基金最近对该公司的持仓进行了调整。先锋集团在第三季度将其在摩特世股票中的持股增加了 3.3%。先锋集团目前持有摩特世医疗仪器供应商的 7,656,891 股股票，价值 2,295,612,000 美元，在此期间又购买了 246,128 股。Fundsmith LLP 在第三季度将其在摩特世股票中的持股增加了 9.6%。Fundsmith LLP 目前持有摩特世医疗仪器供应商的 3,955,498 股股票，价值 1,185,898,000 美元，在此期间又购买了 347,091 股。Janus Henderson Group PLC 在第一季度将其在摩特世股票中的持股增加了 27.0%。Janus Henderson Group PLC 目前持有摩特世医疗仪器供应商的 1,638,772 股股票，价值 488,028,000 美元，在此期间又购买了 348,379 股。Geode Capital Management LLC 在第四季度将其在摩特世股票中的持股增加了 0.5%。Geode Capital Management LLC 目前持有摩特世医疗仪器供应商的 1,593,388 股股票，价值 602,921,000 美元，在此期间又购买了 8,590 股。最后，景顺有限公司在第三季度将其在摩特世股票中的持股增加了 32.3%。景顺有限公司目前持有摩特世医疗仪器供应商的 1,472,419 股股票，价值 441,446,000 美元，在上个季度又购买了 359,596 股。94.01% 的股票目前由机构投资者持有。</p>
</div><h2>Waters Company Profile</h2>
<div class="lb-trans"><h2>摩特世公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.</p>
<div class="lb-trans"><p>摩特世公司是一家全球性的分析仪器、软件和服务提供商，专注于实验室和研究应用。该公司设计、制造和销售以液相色谱、质谱、分离科学及相关样品准备和检测系统为中心的技术。其产品组合包括色谱仪、质谱仪、色谱柱和耗材、实验室信息学和工作流程软件，以及帮助客户进行复杂分析的技术支持和培训服务。</p>
</div><p>Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.</p>
<div class="lb-trans"><p>摩特世服务于广泛的终端市场，包括制药和生物技术公司、合同研究和测试实验室、学术和政府研究机构、临床诊断、食品和环境检测，以及工业和化学制造商。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Waters</li>
<li>FirstCash Turns Pawn Into a Growth Machine</li>
<li>HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?</li>
<li>Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks</li>
<li>The Speed of Light: 5 Stocks Powering AI’s Optical Future</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比沃特世更好</li>
<li>FirstCash 将典当业务转变为增长机器</li>
<li>HubSpot 刚刚击碎了空头论——更大的反弹在前吗？</li>
<li>激进的内部人士买入信号在三只风险股票中显示机会</li>
<li>光速：五只推动人工智能光学未来的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=WAT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Waters Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在沃特世吗？</h2>
</div><p>Before you consider Waters, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑沃特世之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而沃特世并不在名单上。</p>
</div><p>While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然沃特世目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Waters (NYSE:WAT) Price Target Raised to $400.00

Market Beat

美国银行

安捷伦科技

摩根士丹利

富国银行

Illumina

Janus Henderson

景顺投资管理

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

沃特世（NYSE:WAT）的目标股价被上调至 400.00 美元